96 related articles for article (PubMed ID: 6345050)
1. [The antiaggregation effect of ticlopidine on blood platelets preliminary results and prospectives for studies in various diseases].
Andriani A; Chiappetta MG; Fabiani M; Mosiello G; Beni A
Clin Ter; 1983 Feb; 104(3):219-22. PubMed ID: 6345050
[No Abstract] [Full Text] [Related]
2. [Evaluation of platelet aggregation in patients treated with ticlopidine].
Sbalzarini G; Carniti E; Fiorini L; Iezzi BG
Clin Ter; 1984 Nov; 111(3):247-50. PubMed ID: 6240365
[No Abstract] [Full Text] [Related]
3. The effect of oral ticlopidine on arachidonic acid products in human platelets.
Bruno JJ; Chang LF; McSpadden MM; Yang D
Agents Actions Suppl; 1984; 15():76-87. PubMed ID: 6435408
[No Abstract] [Full Text] [Related]
4. Comparative study of platelet aggregation measured with 3 different methods (photometric and impedance) in ticlopidine treated patients.
Lecrubier C; Girard P; Noire P; Samama M
Agents Actions Suppl; 1984; 15():60-7. PubMed ID: 6592946
[No Abstract] [Full Text] [Related]
5. Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
Iovine C; d'Avenia V; Turco S; Mattioli PL; di Minno G
Agents Actions Suppl; 1984; 15():105-7. PubMed ID: 6592941
[No Abstract] [Full Text] [Related]
6. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
Lee H; Paton RC; Ruan C; Caen JP
Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
de Gaetano G; Bertelé V
Arq Bras Cardiol; 1983 Dec; 41(6):425-7. PubMed ID: 6678584
[No Abstract] [Full Text] [Related]
8. Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries.
Verstraete M
Agents Actions Suppl; 1984; 15():173-87. PubMed ID: 6091423
[No Abstract] [Full Text] [Related]
9. Pharmacokinetic and metabolic characteristics of ticlopidine in relation to its inhibitory properties on platelet function.
Picard-Fraire C
Agents Actions Suppl; 1984; 15():68-75. PubMed ID: 6385655
[No Abstract] [Full Text] [Related]
10. In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.
Dunn FW; Soria J; Soria C; Thomaidis A; Lee H; Caen JP
Agents Actions Suppl; 1984; 15():97-104. PubMed ID: 6091425
[No Abstract] [Full Text] [Related]
11. The influence of ticlopidine on the natural course of retinal vein occlusion.
Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J
Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648
[TBL] [Abstract][Full Text] [Related]
12. Ticlopidine in the secondary prevention of early diabetes-related microangiopathy: protocol of a multicenter therapeutic study (TIMAD study).
Mirouze J
Agents Actions Suppl; 1984; 15():230-58. PubMed ID: 6385649
[No Abstract] [Full Text] [Related]
13. [Control of platelet antiaggregation therapy using an electronic aggregometer on whole blood].
Arpaia MR; Leonardo G; del Guercio R
Minerva Cardioangiol; 1986 Apr; 34(4):195-8. PubMed ID: 3725023
[No Abstract] [Full Text] [Related]
14. A platelet aggregation inhibitor--ticlopidine--in diabetic nephropathy: a randomized double blind study.
Nyberg G; Larsson O; Westberg NG; Aurell M; Jagenburg R; Blohmé G
Clin Nephrol; 1984 Mar; 21(3):184-7. PubMed ID: 6705280
[TBL] [Abstract][Full Text] [Related]
15. [Migraine or transient ischemic attacks in a patient with essential thrombocythaemia. Treatment with ticlopidine (author's transl)].
Bousser MG; Conard J; Lecrubier C; Bousser J
Ann Med Interne (Paris); 1980; 131(2):87-90. PubMed ID: 7396326
[TBL] [Abstract][Full Text] [Related]
16. Ticlopidine and platelet function.
Lecompte T; Lecrubier C; Potevin F; Samama M
Thromb Haemost; 1986 Jun; 55(3):437-8. PubMed ID: 3529484
[No Abstract] [Full Text] [Related]
17. Overview: pharmacology of ticlopidine.
Gordon JL
Agents Actions Suppl; 1984; 15():108-15. PubMed ID: 6385643
[No Abstract] [Full Text] [Related]
18. [Changes of blood coagulability and effects of the platelet aggregation inhibitor (ticlopidine) in experimental subarachnoid hemorrhage in dogs].
Toyoda O; Nukui H; Horikoshi S; Mitsuka S; Sasaki H; Tamada J; Miyagi O; Shibasaki T; Ohe C
Neurol Med Chir (Tokyo); 1985 Oct; 25(10):810-7. PubMed ID: 2417133
[No Abstract] [Full Text] [Related]
19. [Changes in platelet aggregation during treatment with acetylsalicylic acid. Sensitivity of various aggregating agents].
Lecrubier C; Conard J; Horellou MH; Kher A; Samama M
Therapie; 1982; 37(5):581-6. PubMed ID: 7179328
[No Abstract] [Full Text] [Related]
20. [The effects of ticlopidine on platelet aggregation: study on 13 atherosclerotic patients].
Lenci R; Galante A; Borzi M; Ariganello M; Sommariva L; Filice A; Cannata D
Clin Ter; 1983 Feb; 104(3):205-9. PubMed ID: 6861457
[No Abstract] [Full Text] [Related]
[Next] [New Search]
